I wanted to pass along information about the ICARA (Bapi) study (www.icarastudy.com).
Its goal is to explore if an investigational drug, called bapineuzumab, can help slow the progression of Alzheimer's disease. There is no charge to participate, and a medical team - including a physician - will monitor participants throughout the study.
It's important to consider participating in clinical studies, such as ones like this that test potential new treatments, as they are the best chance we have for fighting this disease.

Thank you Becky. It seems that there are many widespread places where one may participate. Hope of progress is always encouraging.

http://www.icarastudy.com/index.aspx